Bill
Bill > A5935
summary
Introduced
11/18/2019
11/18/2019
In Committee
11/18/2019
11/18/2019
Crossed Over
Passed
Dead
01/08/2020
01/08/2020
Introduced Session
2018-2019 Regular Session
Bill Summary
This bill provides that carriers that provide coverage for prescription drugs pursuant to the terms of a health benefits plan offered by the carrier are prohibited from requiring a covered person to pay, for a covered prescription insulin drug, an amount exceeding $100 per 30 day supply of insulin, regardless of the amount or type of insulin needed to fill the covered person's prescription. Places cap of $100 on amount paid by covered persons for purchase of insulin.
AI Summary
This bill provides that carriers offering health benefits plans are prohibited from requiring a covered person to pay more than $100 per 30-day supply of covered prescription insulin drugs, regardless of the amount or type of insulin needed. The term "prescription insulin drug" is defined to include articles recognized in official pharmacopoeias that are used to treat diabetes, but excludes biological products and medical devices. The bill will take effect on the first day of the seventh month following the date of enactment, and the Commissioner of Banking and Insurance may take necessary administrative actions in advance.
Committee Categories
Business and Industry
Sponsors (4)
Last Action
Introduced, Referred to Assembly Financial Institutions and Insurance Committee (on 11/18/2019)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bills/BillView.asp?BillNumber=A5935 |
| BillText | https://www.njleg.state.nj.us/2018/Bills/A9999/5935_I1.HTM |
| Bill | https://www.njleg.state.nj.us/2018/Bills/A9999/5935_I1.PDF |
Loading...